Home
About Us
Company History
Direction
The Team
Products
News
Partners
Partnering
Existing Partners
Distribution
Contact
Home
About Us
Company History
Direction
The Team
Products
News
Partners
Partnering
Existing Partners
Distribution
Contact
News
Featured
May 10, 2023
Max Health Pharmacy Innovation Showcase Award 2023
May 10, 2023
Read More →
May 10, 2023
Feb 13, 2023
New Max Health team members - welcoming Lisa Chang and Leanne Carpendale
Feb 13, 2023
Read More →
Feb 13, 2023
Dec 5, 2022
Clinical pharmacist, Fiona McNabb wins Max Health Pharmacy Innovation Showcase Award 2022
Dec 5, 2022
Read More →
Dec 5, 2022
Oct 20, 2022
Levomepromazine Injection – New Tender Listing – Section B and Section H
Oct 20, 2022
Read More →
Oct 20, 2022
Oct 14, 2022
Max Health and Hameln to launch Clindamycin 150mg/mL solution for injection into the New Zealand pharmaceutical market.
Oct 14, 2022
Read More →
Oct 14, 2022
Jul 6, 2022
New Schedule Listings - Alliance Pharmaceuticals
Jul 6, 2022
Read More →
Jul 6, 2022
Apr 4, 2022
New Tender Listing – An Addition to Hameln’s Portfolio
Apr 4, 2022
Read More →
Apr 4, 2022
Mar 28, 2022
Partner Update – A Focus on Hameln
Mar 28, 2022
Read More →
Mar 28, 2022
Mar 15, 2022
Orion Pharma and Max Health Partnership in NZ
Mar 15, 2022
Read More →
Mar 15, 2022
Feb 10, 2022
Octreotide Injection - New Tender Listing - Section B and Section H
Feb 10, 2022
Read More →
Feb 10, 2022
Oct 4, 2021
Oxycodone Injection – New Tender Listing – Section B And Section H
Oct 4, 2021
Read More →
Oct 4, 2021
Sep 3, 2021
Neostigmine Metisulfate Injection – New Tender Listing – Section B and Section H
Sep 3, 2021
Read More →
Sep 3, 2021
Aug 2, 2021
Flumazenil Injection – New Tender Listing – Section H
Aug 2, 2021
Read More →
Aug 2, 2021
Jul 1, 2021
Dopamine Hydrochloride Injection – New Tender Listing – Section H
Jul 1, 2021
Read More →
Jul 1, 2021
Jul 1, 2021
Atropine Sulphate Injection – New Tender Listing – Section H and Section B
Jul 1, 2021
Read More →
Jul 1, 2021